Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001363 · ClinicalTrials.gov registry record
PET Scan to Map the Areas of the Brain Involved in Planning
A clinical trial of Cognition Disorders, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 230
- Enrollment target
- 1
- Study location
NCT00001363: Completed study of Cognition Disorders, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00001363 is a study of Cognition Disorders that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 230 participants, roughly in line with the 250-participant average among 9 other Cognition Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001363, a study of Cognition Disorders, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
Positron Emission Tomography (PET) is a technique used to investigate the functional activity of the brain. The PET technique allows doctors to study the normal processes of the brain (central nervous system) of normal individuals and patients with neurologic illnesses without physical / structural damage to the brain. When a region of the brain is active, it uses more fuel in the form of oxygen and sugar (glucose). As the brain uses more fuel it produces more waste products, carbon dioxide and water. Blood carries fuel to the brain and waste products away from the brain. As brain activity increases blood flow to and from the area of activity increases also. Knowing these facts, researchers can use radioactive water (H215O) and PET scans to observe what areas of the brain are receiving more blood flow. This study will attempt to determine the areas of the brain activated by planning processes and decision making. Researchers will ask patients to participate in tests and games (chess) that will stimulate the areas of the brain involved with decision making and planning while undergoing the water PET blood flow technique.
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 1993-01 |
| Est. Completion | 2001-03 |
What the finished NCT00001363 record still lists
NCT00001363 is an observational study that tracks outcomes without assigning an intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 250-participant average among 9 other Cognition Disorders trials with a reported enrollment target.
The record links to 1 condition, with Cognition Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT00001363 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001363 about?
NCT00001363 is a clinical study titled "PET Scan to Map the Areas of the Brain Involved in Planning". Positron Emission Tomography (PET) is a technique used to investigate the functional activity of the brain. The PET technique allows doctors to study the normal processes of the brain (central nervous system) of normal individuals and patients with neurologic illnesses without physical / structural ...
What is the current status of trial NCT00001363?
This trial is currently completed. The enrollment target is 230 participants. The study started on 1993-01. Estimated completion is 2001-03.
What conditions does trial NCT00001363 study?
This clinical trial studies the following conditions: Cognition Disorders.
Who is sponsoring clinical trial NCT00001363?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001363 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognition Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001363's enrollment target sits among peer trials
230 4th of 9 higher than 6 of 9 other Cognition Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognition Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
ACTIVE NOT RECRUITING
-
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
COMPLETED · Phase 1
-
Therapy for Depressed Elders With Thought Problems
COMPLETED · Phase 3
-
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
COMPLETED
-
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
COMPLETED · Phase 1
-
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia